Pubblicazioni ufficiali Theraclion

Azioni

Tempo reale Euronext Paris Altri mercati azionari 09:00:21 03/06/2024			Variaz. 5gg	Var. 1 gen.
0,374 ^EUR	+2,47%		-10,10%	-3,61%

27/03	Theraclion SA riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Theraclion raggiunge un'importante pietra miliare nel percorso verso il mercato statunitense: I primi pazienti trattati con Sonovein nell'ambito dello studio pivotale approvato dall'FDA	CI

Combined general shareholders meeting	24/05/23	CO
Monthly statement on voting rights	30/04/23	CO
Annual results	28/04/23	CO
Annual results	28/04/23	CO
Financial report	28/04/23	CO
Monthly statement on voting rights	31/03/23	CO
Monthly statement on voting rights	28/02/23	CO
Monthly statement on voting rights	31/01/23	CO
Monthly statement on voting rights	30/11/22	CO
Half-year report	01/11/22	CO
Monthly statement on voting rights	31/10/22	CO
Changes in management and corporate officers	31/10/22	CO
1st-half-year results	26/09/22	CO
1st-half-year results	26/09/22	CO
Monthly statement on voting rights	31/07/22	CO
Monthly statement on voting rights	30/06/22	CO
Monthly statement on voting rights	31/05/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	31/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	07/03/22	CO
Corporate officers' Statement : -Other Types Operations	07/03/22	CO
Corporate officers' Statement : -Other Types Operations	03/03/22	CO
Corporate officers' Statement -: xercise of Stock Options 4	02/03/22	CO
Minutes of the general assembly	07/02/22	CO
Monthly statement on voting rights	31/01/22	CO